Table 3 Laboratory Findings of IM patients with normal and elevated ALT

WBC (×10⁹/L)

15.3 (11.4–19.5)^ab

17.2 (12.8–23.3)^a

13.7 (9.3–19.3)^b

Lymphocyte count(×10⁹/L)

10.4 (6.4–12.7)^a

11.8 (7.4–16.1)^a

3.4 (2.3–5.2)^b

Plasma EBV-DNA lg(copies/ml)

3.7 ± 0.6a

4.1 ± 0.7b

–

ADA (U/L)

45.1 (38.9–49.4)^a

62.3 (53.4–79.3)^b

20.1 (17.1–23.8)^c

IgA (g/L)

1.3 (1.0–1.8) ^a

1.5 (1.0–2.0)^a

0.8 (0.5–1.2)^b

IgG (g/L)

10.4 ± 2.5^a

12.2 ± 2.8^b

7.7 ± 2.2^c

IgM (g/L)

1.4 (1.1–2.0)^a

1.8 (1.4–2.2)^a

1.1 (0.8–1.6)^b

CD3+ (%)

78.1 (71.0–82.8)^a

79.4 (75.0–82.7)^a

63.8 (54.1–71.8)^b

CD3+ CD4+ (%)

19.1 (14.5–23.3)^a

15.6 (12.6–20.6)^a

32.1 (24.8–39.2)^b

CD3+ CD8+ (%)

51.6 ± 10.1^a

56.3 ± 11.4^b

25.0 ± 8.0^c

CD4+/CD8+

0.4 (0.3–0.5)^a

0.3 (0.2–0.4)^a

1.2 (1.0–1.7)^b

CD3-CD(16 + 56)+(%)

11.8 (7.7–16.9)

11.9 (9.0–17.0)

11.1 (6.7–16.1)

CD3-CD19+ (%)

8.1 (5.4–11.8)^a

7.1 (4.4–9.4)^a

20.9(16.0–29.8)^b

CD19 + CD23+ (%)

4.4 (2.4–6.4)^a

3.5 (2.4–6.1)^a

9.9 (6.8–12.7)^b